ACXP vs LRCX · $11.3M cap vs P/E 71, rev $23.23B
Acurx Pharmaceuticals LLC (ACXP) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
Acurx Pharmaceuticals LLC (ACXP) is a biotechnology company listed on US.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ.
ACXP does not have a complete income-statement cache yet.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. Revenue was up 26.0% from 2025-06-29 to 2026-06-28. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
ACXP currently screens at market cap $11.3M. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the ACXP and LRCX stock pages for the full models.
Not investment advice.